Published by Coherent Market Insights
Posted on September 15, 2021
4 min readLast updated: February 10, 2026
Add as preferred source on Google
Electrocardiogram (ECG) is a device that records electrical activity of the heart in waveforms with electrodes, which are placed in contact to the body (chest) and the signals are amplified on the ECG monitor. The interpretation of these waveforms help in identifying symptoms of arrhythmia and acute coronary syndromes.
Major factors hampering the growth of the ECG monitoring systems market during the forecast period constitutes of lengthy medical device approval period. The U.S. FDA has implemented rules for in-vitro testing of Electrocardiogram (ECG) Devices, which includes environmental testing, software testing, electrical safety, and electromagnetic compatibility of the devices. Moreover, the time needed to process and approve 510(K) increased from 90 days to 140 days due to the complexity and volume of medical devices marketing submissions.
Request Sample Copy + related graphs of the report@ https://www.coherentmarketinsights.com/insight/request-sample/4027
Increasing prevalence of cardiovascular diseases is expected to propel growth of the global cardiovascular monitoring and diagnostic devices market over the forecast period. For instance, according to the American Heart Association’s Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of cardiovascular disease in 2016.
Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
ECG Monitoring Equipment held dominant position in the global ECG monitoring systems market in 2019, accounting for 56.5% share in terms of value, followed by Holter Monitoring Systems and ECG Stress Testing Systems, respectively.
R&D in ambulatory ECGs is expected to offer lucrative growth opportunities for players in the global ECG monitoring systems market. For instance, in February 2020, researchers at University of Electronic Science and Technology of China developed an adaptive cancellation algorithm based on multi-inertial sensors to suppress motion artifacts in ambulatory ECGs.
Moreover, increasing investment in development of new devices is also expected to aid in growth of the market. For instance, in December 2019, Biotricity Inc., a medical diagnostic and consumer healthcare technology company, raised US$ 6 million for FDA Filing for its patch solution within the first 6 months of 2020, which will be a novel product in the field of Holter monitoring.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4027
Major players in the market are focused on approval and launch of new devices to expand their product portfolio. For instance, in July 2020, AliveCor released KardiaCare, a digital subscription service that offers a suite of features that helps users interpret their heart data, monitor risk factors, identify symptom triggers and measure the impact of lifestyle changes.
Similarly, in January 2020, VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient monitoring, received the U.S. FDA clearance for its Continuous ECG platform comprising of reusable wearable ECG sensors and associated software development kit
Detailed Segmentation
By Equipment Type:
By End User:
Request Here For PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/4027
Major players operating in the global ECG monitoring systems market include, GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller AG, Opto Circuits (India) Limited, Opto Circuits (India) Limited, Welch Allyn, Fukuda Denshi Co., Ltd., OSI Systems, Lidco Group plc, Biotricity Inc., Bittium Corporation, St. Jude Medical Inc., VivaQuant, and Johnson & Johnson.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post ECG Management Systems Market Growth Driven by the Increasing Prevalence of Heart Disease appeared first on Gatorledger.
The increasing prevalence of cardiovascular diseases is expected to propel growth in the global cardiovascular monitoring and diagnostic devices market.
The growing geriatric population is anticipated to aid in the growth of the ECG management systems market, with projections indicating it will reach 77 million in the U.S.
A major challenge hampering the growth of the ECG monitoring systems market is the lengthy medical device approval period imposed by the U.S. FDA.
Recent advancements include the release of KardiaCare by AliveCor, a digital subscription service, and the U.S. FDA clearance for VivaLNK's Continuous ECG platform.
Major players include GE Healthcare, Philips Healthcare, Nihon Kohden, and Schiller AG, among others.
Explore more articles in the Research Reports category
